FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Info Collection Extension for Emergency Use Guide

Federal Register notice: FDA seeks an information collection extension on its guidance on emergency use authorizations.

Human Drugs

Amarin Planning Synthetic Omega-3 Response

Amarin says it will respond to a citizen petition asking for a synthetic omega-3 exclusion from dietary supplement structural requirements by demonstr...

Federal Register

Draft Guide on Prostate Cancer Drugs

Federal Register notice: FDA makes available a draft guidance entitled Advanced Prostate Cancer: Developing Gonadotropin-Releasing Hormone Analogues....

Human Drugs

Review iPLEDGE Isotretinoin Fetal Defects: Researchers

Researchers call for reevaluation of the iPLEDGE isotretinoin program and exploration of new approaches to lower fetal exposure to the drug.

Medical Devices

Pear Therapeutics Seeks Somryst Marketing OK

Pear Therapeutics says it filed a request for marketing authorization with FDA for its Somryst prescription digital therapeutic to treat chronic insom...

Biologics

Cell Product Deviations at Virginia Center

FDA warns Virginia Center for Reproductive Medicine about repeat deviations from regulations governing human cells, tissues, and cellular and tissue-b...

Human Drugs

Bill Would Speed Generic, Biosimilar Entry: CBO

The Congressional Budget Office says several provisions in Sen. Alexanders Lower Health Care Costs Act would change FDA regulatory authority to speed ...

Medical Devices

Changes Sought in Establishment Inspection Guidance

Two stakeholders suggest changes to an FDA draft guidance on medical device establishment inspection processes and standards.

Federal Register

Info Collection Extension for User Fee Cover Sheet

Federal Register notice: FDA sends to OMB an information collection extension for its medical device user fee cover sheet.

Federal Register

Info Collection Extension for Guide on Influenza A Reagents

Federal Register notice: FDA sends to OMB an information collection extension for its guidance on influenza A reagents.